Literature DB >> 26727107

FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.

Ting Zhang1, Dae Hyun Kim1, Xiangwei Xiao1, Sojin Lee1, Zhenwei Gong1, Radhika Muzumdar1, Virtu Calabuig-Navarro1, Jun Yamauchi1, Hideyoshi Harashima1, Rennian Wang1, Rita Bottino1, Juan Carlos Alvarez-Perez1, Adolfo Garcia-Ocaña1, George Gittes1, H Henry Dong1.   

Abstract

β-Cell compensation is an essential mechanism by which β-cells increase insulin secretion for overcoming insulin resistance to maintain euglycemia in obesity. Failure of β-cells to compensate for insulin resistance contributes to insulin insufficiency and overt diabetes. To understand the mechanism of β-cell compensation, we characterized the role of forkhead box O1 (FoxO1) in β-cell compensation in mice under physiological and pathological conditions. FoxO1 is a key transcription factor that serves as a nutrient sensor for integrating insulin signaling to cell metabolism, growth, and proliferation. We showed that FoxO1 improved β-cell compensation via 3 distinct mechanisms by increasing β-cell mass, enhancing β-cell glucose sensing, and augmenting β-cell antioxidative function. These effects accounted for increased glucose-stimulated insulin secretion and enhanced glucose tolerance in β-cell-specific FoxO1-transgenic mice. When fed a high-fat diet, β-cell-specific FoxO1-transgenic mice were protected from developing fat-induced glucose disorder. This effect was attributable to increased β-cell mass and function. Furthermore, we showed that FoxO1 activity was up-regulated in islets, correlating with the induction of physiological β-cell compensation in high-fat-induced obese C57BL/6J mice. These data characterize FoxO1 as a pivotal factor for orchestrating physiological adaptation of β-cell mass and function to overnutrition and obesity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26727107      PMCID: PMC4769368          DOI: 10.1210/en.2015-1852

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  65 in total

Review 1.  Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion.

Authors:  Mira M Sachdeva; Doris A Stoffers
Journal:  Mol Endocrinol       Date:  2009-02-05

2.  mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability.

Authors:  Norman Balcazar; Aruna Sathyamurthy; Lynda Elghazi; Aaron Gould; Aaron Weiss; Ichiro Shiojima; Kenneth Walsh; Ernesto Bernal-Mizrachi
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

3.  Overexpression of FoxO1 causes proliferation of cultured pancreatic beta cells exposed to low nutrition.

Authors:  Jianzhong Ai; Jingjing Duan; Xiaoyan Lv; Mianzhi Chen; Qiutan Yang; Huan Sun; Qingwei Li; Yan Xiao; Yidong Wang; Zheng Zhang; Ruizhi Tan; Yuhang Liu; Danhua Zhao; Tielin Chen; Yang Yang; Yuquan Wei; Qin Zhou
Journal:  Biochemistry       Date:  2010-01-12       Impact factor: 3.162

4.  Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.

Authors:  Karsten Müssig; Harald Staiger; Fausto Machicao; Alena Stancáková; Johanna Kuusisto; Markku Laakso; Claus Thamer; Jürgen Machann; Fritz Schick; Claus D Claussen; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

5.  Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans.

Authors:  Juris J Meier; Alexandra E Butler; Yoshifumi Saisho; Travis Monchamp; Ryan Galasso; Anil Bhushan; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2008-03-11       Impact factor: 9.461

6.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.

Authors:  Adama Kamagate; Shen Qu; German Perdomo; Dongming Su; Dae Hyun Kim; Sandra Slusher; Marcia Meseck; H Henry Dong
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1.

Authors:  Tadahiro Kitamura; Yukari Ido Kitamura; Masaki Kobayashi; Osamu Kikuchi; Tsutomu Sasaki; Ronald A Depinho; Domenico Accili
Journal:  Mol Cell Biol       Date:  2009-06-08       Impact factor: 4.272

8.  Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas.

Authors:  M Al-Masri; M Krishnamurthy; J Li; G F Fellows; H H Dong; C G Goodyer; R Wang
Journal:  Diabetologia       Date:  2009-12-24       Impact factor: 10.122

9.  Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents.

Authors:  Senta Georgia; Charlotte Hinault; Dan Kawamori; Jiang Hu; John Meyer; Murtaza Kanji; Anil Bhushan; Rohit N Kulkarni
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

10.  Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice.

Authors:  Klaus Pechhold; Kerstin Koczwara; Xiaolong Zhu; Victor S Harrison; Greg Walker; Janet Lee; David M Harlan
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more
  26 in total

1.  SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes.

Authors:  Xiangwei Xiao; Shane Fischbach; Tina Zhang; Congde Chen; Qingfeng Sheng; Ray Zimmerman; Sneha Patnaik; Joseph Fusco; Yungching Ming; Ping Guo; Chiyo Shiota; Krishna Prasadan; Nupur Gangopadhyay; Sohail Z Husain; Henry Dong; George K Gittes
Journal:  Diabetes       Date:  2017-08-03       Impact factor: 9.461

2.  Myt Transcription Factors Prevent Stress-Response Gene Overactivation to Enable Postnatal Pancreatic β Cell Proliferation, Function, and Survival.

Authors:  Ruiying Hu; Emily Walker; Chen Huang; Yanwen Xu; Chen Weng; Gillian E Erickson; Anastasia Coldren; Xiaodun Yang; Marcela Brissova; Irina Kaverina; Appakalai N Balamurugan; Christopher V E Wright; Yan Li; Roland Stein; Guoqiang Gu
Journal:  Dev Cell       Date:  2020-04-30       Impact factor: 12.270

3.  Long-term c-Kit overexpression in beta cells compromises their function in ageing mice.

Authors:  Amanda Oakie; Zhi-Chao Feng; Jinming Li; Jenna Silverstein; Siu-Pok Yee; Rennian Wang
Journal:  Diabetologia       Date:  2019-06-01       Impact factor: 10.122

Review 4.  FoxO integration of insulin signaling with glucose and lipid metabolism.

Authors:  Sojin Lee; H Henry Dong
Journal:  J Endocrinol       Date:  2017-02-17       Impact factor: 4.286

5.  APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Xiaoyun Cheng; Jun Yamauchi; Sojin Lee; Ting Zhang; Zhenwei Gong; Radhika Muzumdar; Shen Qu; H Henry Dong
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

Review 6.  Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.

Authors:  Usman Sabir; Hafiz Muhammad Irfan; Ihtisham Umer; Zahid Rasul Niazi; Hafiz Muhammad Mazhar Asjad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-31       Impact factor: 3.000

Review 7.  Fox transcription factors: from development to disease.

Authors:  Maria L Golson; Klaus H Kaestner
Journal:  Development       Date:  2016-12-15       Impact factor: 6.868

8.  Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.

Authors:  Yun-Zi Liu; Xiaoyun Cheng; Ting Zhang; Sojin Lee; Jun Yamauchi; Xiangwei Xiao; George Gittes; Shen Qu; Chun-Lei Jiang; H Henry Dong
Journal:  J Biol Chem       Date:  2016-05-11       Impact factor: 5.157

Review 9.  (Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives.

Authors:  Luc Baeyens; Marie Lemper; Willem Staels; Sofie De Groef; Nico De Leu; Yves Heremans; Michael S German; Harry Heimberg
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 10.  Role of FoxO1 in regulating autophagy in type 2 diabetes mellitus (Review).

Authors:  Xiudan Li; Tingting Wan; Yanbo Li
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.